Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/2441
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIYUN, A O.-
dc.contributor.authorTUCKER, G.T.-
dc.date.accessioned2024-07-26T14:18:19Z-
dc.date.available2024-07-26T14:18:19Z-
dc.date.issued1982-
dc.identifier.citationAfr. J. Med. med. Sci. (1982) 11.7-9.en_US
dc.identifier.issn1116-4077-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/2441-
dc.descriptionARTICLEen_US
dc.description.abstractAntipyrine was given orally to five patients with Chronic renal failure and nine normal subjects. Plasma antipyrine levels were measured by high pressure liquid chromatography method, the plasma half-life of the drug was determined and used as an index of drug oxidation. The mean (±s.d.) plasma antipyrine half-life in patients with chronic renal failure (7-8 ± 2-6 h) was significantly shorter than in normal subjects (13-1 ± 2-3 h) (P > 0-001). There was no significant difference in the volume of distribution but there was a significant difference in the clearance in ml.kg-'h-' (P < 0 001). The results suggest that oxidation of antipyrine by hepatic microsomal enzymes is increased in patients with chronic renal failure. The role of this in the apparent resistance among our patients to antihypertensive agents needs further study.en_US
dc.description.sponsorshipCOLLEGE OF MEDICINEen_US
dc.language.isoenen_US
dc.publisherBLACKWELL SCIENTIFIC PUBLICATIONSen_US
dc.subjectpatientsen_US
dc.subjectChronic renal failureen_US
dc.subjectdrugen_US
dc.subjectoxidationen_US
dc.titleANTIPYRINE KINETICS IN NIGERIAN WOMEN IN CHRONIC RENAL FAILUREen_US
dc.typeArticleen_US
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Iyun_Tucker_Antipyrine_1982.pdfARTICLE5.63 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.